MGRC (0155) Stock Overview

Malaysian Genomics Resource Centre Berhad, an investment holding company, provides genetics, genomics, immunotherapy, and biopharmaceutical services worldwide. The company's services include sequencing and analysis of various human, animal, plant, and microbial genomes. It offers sequencing services, such as whole genome and transcriptome sequencing, and metagenomics and metatranscriptomics services. The company also provides bioinformatics services, including reads quality analysis, whole genome assembly, variation analysis of genomes, gene annotation, and exome and transcriptome analysis, as well as other analytical pipelines for processing ChIP-Seq data, annotating and analyzing microRNAs, and analyzing mutations; trait analysis services to screen multiple samples of previously identified genetic markers within plant and animal genomes; and trio sequencing services that provide a detailed view of an individual's DNA. In addition, it offers genetic screening and cancer immunotherapy services. Further, the company engages in the business relating to life sciences/cell laboratory and its byproducts; general medical services; and supply of healthcare products and services. Malaysian Genomics Resource Centre Berhad was incorporated in 2004 and is headquartered in Petaling Jaya, Malaysia.